March 2024 Update
Your quarterly update from the MCGI team
January 2024 —March 2024
2024 MCGI Forum Enduring Content Access
On April 12-13, 2024, the MCGI community came together once again for the 7th annual MCGI Forum, hosted virtually and in person at the Portland Sheraton in South Portland, ME. The MCGI team extends thanks to all who attended, both within the MCGI network and the external precision oncology community. We hope you enjoyed your experience and gained valuable insights that you can implement into your community oncology practice.
If you missed us, it’s not too late to catch up on all the content. Register as a virtual attendee to view select presentation recordings on our enduring content platform. These recordings will be accessible until Friday, May 17, 2024.
For those who were able to join us, we’d love to hear your feedback!
Click here to complete the post-Forum evaluation.
To claim continuing education credit, please complete the post-Forum evaluation by May 17th. Attendees are not required to participate in all sessions to earn credit and may earn partial credit by choosing to attend/view only some sessions.
For more details on continuing education credits, visit our event page. We look forward to sharing an event recap with you soon.
MCGI Team Organizational Updates
In March, we implemented several organizational changes within the MCGI team to enhance support for our existing programs and foster future growth.
-
Leah Graham has stepped into the role of Program Director. In this capacity, she will oversee all MCGI activities.
-
Lindsey Kelley has been appointed as Associate Director. She will work closely with Leah on program development and oversee the Genomic Tumor Board (GTB) program.
-
Jennifer Bourne has assumed the role of Operations Manager and will continue to manage the day-to-day operations of the initiative.
Please join us in congratulating Leah, Lindsey, and Jennifer on their new roles! For more information about the MCGI team, visit our website.
Biomarker Testing Results Discussion Guide
Do you want your patients to know more about how biomarker testing is impacting their treatment and clinical trial options? The new Biomarker Testing Discussion Guide, created in collaboration with patients and providers from different cancer experiences and expertise, can help them understand their results.
Customize the guide with your organization’s logo and host on your site: www.lungevity.org/biomarkerdiscussionguide
Stay Connected
Connect with us online and be part of the MCGI community!